Skip to main content
Aprogen, Inc logo

Aprogen, Inc — Investor Relations & Filings

Ticker · 007460 ISIN · KR7007460009 KO Manufacturing
Open in API
Filings indexed 718 across all filing types
Latest filing 2026-01-30 Investor Presentation
Country KR South Korea
Listing KO 007460

About Aprogen, Inc

https://www.aprogen.com/en/v.do?a=Main

Aprogen, Inc. is a biopharmaceutical company focused on the research, development, and manufacturing of biologic medicines. The company's core activities are centered on developing both biosimilars and novel drugs, including new protein therapeutics and bispecific antibodies. Its product development is based on proprietary technologies in antibody engineering and recombinant protein engineering.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최(안내공시)
Investor Presentation Classification · 1% confidence The document is a short announcement (under 800 characters) notifying the public about an upcoming Investor Relations (IR) event (기업설명회). It provides the date, location, and purpose of the meeting but does not contain the actual presentation materials. According to the 'Menu vs Meal' rule, an announcement of an event or report is classified as a Regulatory Filing (RNS) when it does not fit into more specific categories like RPA (which is typically for report publication). Since this is a standard regulatory notice for an IR event, RNS is the appropriate classification.
2026-01-30 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 1% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding the 'Decision to Issue Convertible Bonds' (전환사채권 발행결정) and specifically acts as a 'Correction Report' (정정신고) for a previously filed issuance decision. It details changes to maturity dates, interest payment methods, and conversion periods for convertible bonds. This type of regulatory filing in the Korean market (DART system) is classified as a Capital/Financing Update (CAP) as it pertains to the company's capital structure and debt financing activities.
2026-01-20 Korean
[기재정정]투자판단관련주요경영사항 (독점실시권 라이선스 계약(면역항암제 기술도입 계약))
M&A Activity Classification · 1% confidence The document is a regulatory filing from the Korean Exchange (KRX) system, specifically a 'Correction Report' (정정신고) regarding a previous 'Major Management Matter' (투자판단 관련 주요경영사항) concerning a licensing agreement. Since this document details a specific corporate event (a licensing deal) and its subsequent amendment, it falls under the category of general regulatory announcements that do not fit into more specific categories like M&A or financial reports. Therefore, it is classified as a Regulatory Filing (RNS).
2026-01-02 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. This document details changes in share ownership, including potential shares (convertible bonds) and management influence, by a major shareholder and their special related parties. This falls under the category of Major Shareholding Notification.
2025-12-31 Korean
[기재정정]투자판단관련주요경영사항
Management Reports Classification · 1% confidence The document is a regulatory filing from the Korea Exchange (KRX) system, specifically a 'Correction Report' (정정신고) regarding a 'Major Management Matter' (투자판단 관련 주요경영사항) concerning a joint development agreement. Since this is a formal regulatory announcement of a material business event (contract amendment) filed through the official exchange system, it falls under the 'Regulatory Filings' category.
2025-12-30 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. This document is commonly referred to as a '5% Rule' filing or 'Major Shareholding Notification'. It details the shareholding status, changes in ownership, and collateral agreements of major shareholders. Based on the provided filing categories, this fits the 'Major Shareholding Notification' (MRQ) classification.
2025-12-26 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.